G
Gordon H. Guyatt
Researcher at McMaster University
Publications - 1749
Citations - 262329
Gordon H. Guyatt is an academic researcher from McMaster University. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 231, co-authored 1620 publications receiving 228631 citations. Previous affiliations of Gordon H. Guyatt include Memorial Sloan Kettering Cancer Center & Cayetano Heredia University.
Papers
More filters
Journal ArticleDOI
Measuring Capacity to Complete an Advance Directive
D. William Molloy,Michel Silberfeld,Peteris Darzins,Gordon H. Guyatt,Peter Singer,Bonnie Rush,Michel Bédard,David Strang +7 more
TL;DR: To validate reference standards for the assessment of capacity to complete an advance directive and to develop and test three simple screening instruments.
Journal ArticleDOI
Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine
Alexander P.J. Vlaar,Simon Oczkowski,Sanne de Bruin,Marije Wijnberge,Massimo Antonelli,Cécile Aubron,Philippe Aries,Jacques Duranteau,Nicole P. Juffermans,Jens Meier,Gavin J. Murphy,Riccardo Abbasciano,Marcella C.A. Müller,Akshay Shah,Akshay Shah,Anders Perner,Sofie Rygaard,Timothy S. Walsh,Gordon H. Guyatt,Joanna C. Dionne,Maurizio Cecconi +20 more
TL;DR: This clinical practice guideline provides evidence-based recommendations and identifies areas where further research is needed regarding transfusion practices and transfusion avoidance in non-bleeding, critically ill adults.
Journal ArticleDOI
Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study.
Maaike Buskermolen,Dayna R. Cenin,Dayna R. Cenin,Lise Mørkved Helsingen,Lise Mørkved Helsingen,Gordon H. Guyatt,Per Olav Vandvik,Ulrike Haug,Ulrike Haug,Michael Bretthauer,Michael Bretthauer,Iris Lansdorp-Vogelaar +11 more
TL;DR: Over a 15 year period, all screening strategies may reduce colorectal cancer mortality to a similar extent, and Colonoscopy and sigmoidoscopy may also reduce colorescopy cancer incidence, while FIT shows a smaller incidence reduction.
Journal ArticleDOI
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
Kari A.O. Tikkinen,Kari A.O. Tikkinen,Philipp Dahm,Lyubov Lytvyn,Anja Fog Heen,Robin W.M. Vernooij,Reed A C Siemieniuk,Russell Wheeler,Bill Vaughan,Awah Cletus Fobuzi,Marco H. Blanker,Noelle Perron Junod,Johanna Sommer,Jérôme Stirnemann,Manabu Yoshimura,Reto Auer,Reto Auer,Helen Macdonald,Gordon H. Guyatt,Per Olav Vandvik,Thomas Agoritsas,Thomas Agoritsas +21 more
TL;DR: The CAP Randomized Clinical Trial (CAP-RCT) as mentioned in this paper was a large scale, cluster randomised trial on PSA screening in men without a previous diagnosis of prostate cancer published in 2018.
Journal ArticleDOI
A treatment decision aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial
Michael R. Nannenga,Victor M. Montori,Audrey J. Weymiller,Steven A. Smith,Teresa J.H. Christianson,Sandra C. Bryant,Amiram Gafni,Cathy Charles,Cathy Charles,Rebecca J. Mullan,Lesley A. Jones,Lesley A. Jones,Enrique R. Boloña,Gordon H. Guyatt +13 more
TL;DR: This work sought to determine the impact of a decision aid to help patients with diabetes decide about statins (Statin Choice) on patients’ trust in the clinician.